Theralase’s (TSXV:TLT) Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1.
Vous n'êtes pas connecté
Maroc - THEMARKETHERALD.CA - A La Une - 14/Nov 11:59
Theralase’s (TSXV:TLT) Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1.
Theralase’s (TSXV:TLT) Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1.
A new bladder cancer treatment called TAR-200 has shown impressive results in a recent clinical trial. The study found that 82% of patients with...
A new bladder cancer treatment called TAR-200 has shown impressive results in a recent clinical trial. The study found that 82% of patients with...
Highlights: People with type 1 diabetes are found to have a 4 times higher risk of bladder cancer Adjusting f
People with type 1 diabetes face a higher risk of bladder cancer once the influence of smoking is properly separated.
People with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, according to a systematic...
Bladder cancer ranks among the ten most common types of cancer worldwide. The main treatment is bladder removal surgery, and despite advances in...
DelveInsight’s, “Non Muscle Invasive Bladder Cancer Pipeline Insight 2025” report provides comprehensive insights about 20+...
DelveInsight’s, “Non Muscle Invasive Bladder Cancer Pipeline Insight 2025” report provides comprehensive insights about 20+...
Herbal medicine has long been explored for its potential in cancer prevention and treatment. Modern scientific studies now support the idea that...